Advanced search

Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.

(1997) THROMBOSIS AND HAEMOSTASIS. 77(4). p.650-655
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Vanholder, Raymond, A CAMEZ, Nic Veys, A VANLOO, Annemieke Dhondt, and Severin Ringoir. 1997. “Pharmacokinetics of Recombinant Hirudin in Hemodialyzed End-stage Renal Failure Patients.” Thrombosis and Haemostasis 77 (4): 650–655.
APA
Vanholder, R., CAMEZ, A., Veys, N., VANLOO, A., Dhondt, A., & Ringoir, S. (1997). Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. THROMBOSIS AND HAEMOSTASIS, 77(4), 650–655.
Vancouver
1.
Vanholder R, CAMEZ A, Veys N, VANLOO A, Dhondt A, Ringoir S. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients. THROMBOSIS AND HAEMOSTASIS. 1997;77(4):650–5.
MLA
Vanholder, Raymond, A CAMEZ, Nic Veys, et al. “Pharmacokinetics of Recombinant Hirudin in Hemodialyzed End-stage Renal Failure Patients.” THROMBOSIS AND HAEMOSTASIS 77.4 (1997): 650–655. Print.
@article{182936,
  author       = {Vanholder, Raymond and CAMEZ, A and Veys, Nic and VANLOO, A and Dhondt, Annemieke and Ringoir, Severin},
  issn         = {0340-6245},
  journal      = {THROMBOSIS AND HAEMOSTASIS},
  language     = {eng},
  number       = {4},
  pages        = {650--655},
  title        = {Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.},
  volume       = {77},
  year         = {1997},
}